tirzepatide day 3 3: Mounjaro (Tirzepatide – weekly injection) Class: Dual GLP-1 and GIP receptor agonist Avg Weight Loss: ~20% of baseline weight (SURMOUNT-1 trial) FDA Status: Approved for type 2 diabetes; Fast-tracked for Week 3 done. 4kg down.

A new study from the NYU Grossman School of Medicine, led by Lucas Mavromatis, suggests that #GLP1 receptor agonists - like #Ozempic #Semaglutide and #Zepbound #Tirzepatide - may do more than manage #diabetes and #weight: they could also help reduce the risk of 14 #obesity-related #cancers, especially in women

So how much do you need to drink to get to .08

Distributing protein evenly across meals (25-30g per meal) optimises muscle protein synthesis and helps meet daily targets

If you experience any suspected side effects from medications, report them via the MHRA Yellow Card scheme

However, room-temperature injection remains the preferred method for patient comfort and optimal absorption consistency

They don't want to worry about remembering, 'OK, it's this week, and I have to take it the following week.' So it's just easier to fit into your life when you have a pill," ABC News chief medical correspondent Dr